Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Appleby says it advised on Frazier Life Sciences Acquisition Corp. II’s $75 million IPO
Appleby said it acted as Cayman Islands counsel to Frazier Life Sciences Acquisition Corp. II on its $75 million initial public offering. The firm said the biotechnology-focused acquisition company is sponsored by Frazier Life Sciences, which it described as a long-established biotech investor with venture and public-market strategies.
Key points
- Appleby said the offering comprised 7,500,000 Class A ordinary shares priced at $10.00 each.Appleby
- The firm said trading began on the Nasdaq Capital Market on October 14 under FLSC.Appleby
- Appleby said Alexandra Low led its team.Appleby
- The firm said the team included James Kitching, Alejandra Saucedo Gonzalez, Sophia Cunningham and Emily McIntyre.Appleby